• Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
*

€620k

Seed
Total Funding000k
Notes (0)
More about ArcaScience
Made with AI
Edit

ArcaScience, established in 2018, operates an AI-driven platform designed to enhance drug development decisions. The company's primary clients are pharmaceutical companies and contract research organizations (CROs). By leveraging artificial intelligence, the platform analyzes extensive datasets to extract insights that can optimize the entire drug lifecycle.

The core of ArcaScience's offering is its ability to process and interpret complex biological and clinical data, aiming to accelerate the delivery of new treatments to patients. The company has established partnerships with major industry players, including Sanofi, Takeda, and Roche, indicating a focus on collaborative efforts within the pharmaceutical sector.

The business model appears to be centered on providing its AI platform as a service to its partners, helping them to make more informed decisions in their drug development processes. This approach is positioned to reduce the time and cost associated with bringing new therapies to market.

Keywords: AI in drug discovery, pharmaceutical data analysis, clinical trial optimization, drug lifecycle management, CRO services, precision medicine, big data in pharma, therapeutic development, computational biology, healthcare AI

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads